InvestorsObserver
×
News Home

Should You Buy InterCure Ltd (INCR) Stock Wednesday Morning?

Wednesday, September 06, 2023 07:24 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy InterCure Ltd (INCR) Stock Wednesday Morning?

InterCure Ltd (INCR) has risen Wednesday morning, with the stock gaining 2.41% in pre-market trading to 1.7. INCR's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 117 out of 146 industries, the stock ranks higher than 22% of stocks. InterCure Ltd has risen 7.79% over the past month, closing at $1.58 on August 9. During this period of time, the stock fell as low as $1.39 and as high as $1.67. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.

Overall Score - 39
INCR has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on INCR!
InterCure Ltd has a Long-Term Technical rank of 26. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 74% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 100 by this metric, INCR ranks better than 100% of stocks.

Important Dates for Investors in INCR:

-We do not have a set earnings date for InterCure Ltd at this time. -We do not have a set dividend date for InterCure Ltd at this time. Click Here To Get The Full Report on InterCure Ltd (INCR)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App